Skip to content
The Policy VaultThe Policy Vault

Mytesi (crofelemer)United Healthcare

HIV/AIDS associated diarrhea in adult patients on antiretroviral therapy

Initial criteria

  • Diagnosis of HIV/AIDS associated diarrhea
  • Patient is on antiretroviral therapy

Reauthorization criteria

  • Documentation of positive clinical response to Mytesi therapy

Approval duration

12 months